Clinical Tools That Measure Sitting Posture, Seated Postural Control or Functional Abilities in Children With Motor Impairments: A Systematic Review.
Clinical tools that measure sitting posture, seated postural control or functional abilities in children with motor impairments: a systematic review.
Clin Rehabil. 2013 Jul 15;
Field D, Livingstone R
Objective:To identify and critically appraise clinical measurement tools used to… Continue reading
Effects of Propofol, a Sedative-Hypnotic Drug, on the Lipid Profile, Antioxidant Indices, and Cardiovascular Marker Enzymes in Wistar Rats.
Effects of propofol, a sedative-hypnotic drug, on the lipid profile, antioxidant indices, and cardiovascular marker enzymes in wistar rats.
ISRN Pharmacol. 2013; 2013: 230261
Adaramoye OA, Akinwonmi O, Akanni O
In recent years, the activity of anaesthetic propofol on… Continue reading
Assessing Quality of Life in the Treatment of Patients With Age-Related Macular Degeneration: Clinical Research Findings and Recommendations for Clinical Practice.
Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice.
Clin Ophthalmol. 2013; 7: 1325-32
Yuzawa M, Fujita K, Tanaka E, Wang EC
The importance of incorporating quality-of-life… Continue reading
Massage Therapy and Exercise Therapy in Patients With Multiple Sclerosis: A Randomized Controlled Pilot Study.
Massage therapy and exercise therapy in patients with multiple sclerosis: a randomized controlled pilot study.
Clin Rehabil. 2013 Jul 4;
Negahban H, Rezaie S, Goharpey S
Objective:The primary aim was to investigate the comparative effects of massage therapy and… Continue reading
Safety, Anxiety and Natalizumab Continuation in JC Virus-Seropositive MS Patients.
Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients.
Mult Scler. 2013 Jul 4;
van Rossum JA, Vennegoor A, Balk L, Uitdehaag BM, Polman CH, Killestein J
The use of natalizumab in multiple sclerosis has been restricted by… Continue reading
PEGylated Interferon Beta-1a in the Treatment of Multiple Sclerosis – an Update.
PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update.
Biologics. 2013; 7: 131-138
Reuss R
Current standard immunomodulatory therapy with interferons (IFNs) for relapsing-remitting multiple sclerosis (MS) exhibits proven, but limited, efficacy and increased side effects… Continue reading